Search Documents and Resources

    • Mission and Vision
    • Board & Staff
    • Financials
    • Contact Us
    • Privacy Policy
    • Donor Privacy Policy
    • Explore our work
    • Center for Defense Information
    • The Constitution Project
    • Congressional Oversight Initiative
    • Policy Letters
    • Reports
    • Testimony
    • For Oversight Staff
    • Whistleblower Resources
    • Report Corruption
    • Act Now
    • Stay Informed
  • Sign Up
  • Donate
  • facebook
  • twitter
  • instagram
  • youtube
    • Mission and Vision
    • Board & Staff
    • Financials
    • Contact Us
    • Privacy Policy
    • Donor Privacy Policy
    • Explore our work
    • Center for Defense Information
    • The Constitution Project
    • Congressional Oversight Initiative
    • Policy Letters
    • Reports
    • Testimony
    • For Oversight Staff
    • Whistleblower Resources
    • Report Corruption
Project On Government Oversight
    • Act Now
    • Stay Informed
  • Sign Up
  • Donate
  • Afghanistan
  • More Topics
  • About
  • Mission & History
  • Board & Staff
  • Financials
  • Take Action
  • For Federal Employees
  • COVID-19: Tips
  • Contact Us
  • Privacy Policy
  • Subscribe
  • Donate
Project On Government Oversight
    • Mission and Vision
    • Board & Staff
    • Financials
    • Contact Us
    • Privacy Policy
    • Donor Privacy Policy
    • Explore our work
    • Center for Defense Information
    • The Constitution Project
    • Congressional Oversight Initiative
    • Policy Letters
    • Reports
    • Testimony
    • For Oversight Staff
    • Whistleblower Resources
    • Report Corruption
    • Act Now
    • Stay Informed
  • Sign Up
  • Donate
series

Drug Problems

Investigating the intersection of pharmaceutical dollars and federal policy.

Latest

Hearing Without Listening

analysis | December 16, 2020

Read

Latest

FDA Panel Reviewing Pfizer Vaccine Leaves Out Some Experts Who Raised Concerns

investigation | December 9, 2020

Read
  • FDA Whitewashes Warnings About Coronavirus Vaccine Trials

    analysis | November 2, 2020

  • Some FDA Advisors Tapped to Review Coronavirus Vaccines Received Payments from Vaccine Companies

    investigation | October 21, 2020

  • Coronavirus Relief Act Gives Drug Makers New Sway Over FDA

    investigation | May 5, 2020

  • Following the (Drug) Money

    investigation | May 5, 2020

  • Tainted Prescriptions: Big Pharma's Ties to Experts Advising Congress on Drug Costs

    investigation | January 28, 2019

  • FDA Set Low Bar for Approval of Blood Thinners

    analysis | December 12, 2016

  • Drug Money: FDA Depends on Industry Funding; Money Comes with “Strings Attached”

    investigation | December 1, 2016

  • Drug Money: In FDA Meetings, "Voice" of the Patient Often Funded by Drug Companies

    investigation | December 1, 2016

Previous 1 2 Next

Site Footer

  • facebook
  • twitter
  • instagram
  • youtube
  • Press Center
  • Contact Us
  • Careers
  • Briefing
  • Newsletters
  • Publications
  • Report Corruption
Better Business Bureau Accredited Charity CharityWatch Top Rated Charity Great Nonprofits 2021 Top-Rated Charity Navigator Four-Star Charity

©2022 POGO | Privacy Policy

Project On Government Oversight logo

Project On Government Oversight